(Monrovia, Liberia, September 23, 2025) – The Ministry of Health (MOH) has introduced the BPaL/M regimen in the country, a shorter, all-oral treatment for Drug-Resistant Tuberculosis (DR-TB), marking an advancement in Liberia’s fight against the disease.

The BPaL/M regimen represents a major shift from lengthy treatments that could extend to 20 months. It shortens the treatment course between 6 and 9 months, using only oral medications. It simplifies the process for patients, minimizes side effects, and is proven to yield better health outcomes.

This project is being implemented through the National Leprosy and TB Control Program (NLTCP), with support from The Global Fund and partners including PLAN International, Partners In Health (PIH), and the World Health Organization (WHO).

Another component of the rollout is a five-day intensive training workshop (September 22-26, 2025) for clinicians from TB Annex, JJ Dossen, and Ganta Rehab Hospitals. The training aims to equip frontline health workers with the latest skills for the prevention, diagnosis, and management of DR-TB in line with national guidelines.

The introduction of the BPaL/M regimen signifies the Government of Liberia’s dedication to expanding access to modern, patient-centered care and strengthening the national health system’s capacity to manage infectious diseases.